The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

The authors evaluate the effect and safety of biosimilar trastuzumab MYL-1401O in human epidermal growth factor receptor 2 (HER2)–positive early-stage (neoadjuvant and adjuvant therapy) and metastatic ...

MYL-1701P displayed similar efficacy, safety, and immunogenicity when compared with reference aflibercept to treat diabetic macular edema. Aflibercept is an intravitreal drug approved by the FDA for ...

A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with ...

Mylan (MYL) shares are dropping after Teva Pharmaceuticals withdrew its unsolicited $40 billion takeover bid today.

The S&P 500 got less than half a point away from hitting a record high on Tuesday, but it just wasn't meant to be. When all was said and done, stocks gave up most of their intraday gain, with the S&P ...

Incidence of solid tumors or lymphoma in patients with polycythemia vera: Data from the REVEAL study.

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (MYL). However, you won't necessarily see their names in the company’s annual report, as ...